Clinical Trials
11
Trial Phases
2 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp
- Conditions
- Actinic Keratosis
- Interventions
- First Posted Date
- 2017-01-18
- Last Posted Date
- 2017-11-07
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Registration Number
- NCT03024060
- Locations
- 🇺🇸
Therapeutics Clinical Research, San Diego, California, United States
🇺🇸Altman Dermatology Associates, Arlington Heights, Illinois, United States
🇺🇸Shideler Clinical Research Center, Carmel, Indiana, United States
Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face
- Conditions
- Actinic Keratosis
- Interventions
- Drug: Topical Solution VehicleDevice: IBL 10 mWDevice: IBL 20 mWProcedure: Microneedle lesion preparation
- First Posted Date
- 2015-12-16
- Last Posted Date
- 2018-01-18
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 137
- Registration Number
- NCT02632110
- Locations
- 🇺🇸
UCSD Dermatology, San Diego, California, United States
🇺🇸Therapeutics Clinical Research, San Diego, California, United States
🇺🇸MOORE Clinical Research, Inc, Brandon, Florida, United States
Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)
- Conditions
- Keratosis, Actinic
- Interventions
- Drug: Aminolevulinic Acid (ALA)Device: BLU-U
- First Posted Date
- 2015-12-11
- Last Posted Date
- 2017-09-18
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT02628236
- Locations
- 🇺🇸
DermResearch, Inc., Austin, Texas, United States
🇺🇸J&J Studies, Inc, College Station, Texas, United States
Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick
- Conditions
- Keratosis, Actinic
- Interventions
- Drug: Aminolevulinic Acid (ALA)Device: BLU-U
- First Posted Date
- 2014-11-02
- Last Posted Date
- 2017-01-13
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT02281136
- Locations
- 🇺🇸
Therapeutics Clinical Research, San Diego, California, United States
🇺🇸Shideler Clinical Research Center, Carmel, Indiana, United States
🇺🇸DermResearch, Inc., Austin, Texas, United States
Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy
- Conditions
- Actinic Keratosis
- Interventions
- First Posted Date
- 2014-09-15
- Last Posted Date
- 2018-08-24
- Lead Sponsor
- DUSA Pharmaceuticals, Inc.
- Target Recruit Count
- 166
- Registration Number
- NCT02239679
- Locations
- 🇺🇸
UCSD Dermatology, San Diego, California, United States
🇺🇸Therapeutics Clinical Research, San Diego, California, United States
🇺🇸Altman Dermatology Associates, Arlington Heights, Illinois, United States
- Prev
- 1
- 2
- 3
- Next